| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/19/2009 | CA2696288A1 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2695989A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections |
| 02/19/2009 | CA2695753A1 Compounds useful as protein kinases inhibitors |
| 02/19/2009 | CA2695251A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | CA2694666A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 02/19/2009 | CA2694058A1 Fused bicyclic pyrimidines |
| 02/19/2009 | CA2693162A1 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | CA2691512A1 Heteroaryl amide analogues |
| 02/18/2009 | EP2025678A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase |
| 02/18/2009 | EP2024371A1 Phenanthrene derivatives as mpges-1 inhibitors |
| 02/18/2009 | EP2024369A2 Novel process for the preparation of sildenafil citrate |
| 02/18/2009 | EP2024368A2 6,7,8,9-tetrahydro-5h-pyrimido[4,5-d]azepin-4-yl]-amine derivatives as modulators of trpv1 for the treatment of pain |
| 02/18/2009 | EP2024367A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 02/18/2009 | EP2024366A2 Monocyclic heteroaryl compounds |
| 02/18/2009 | EP2024360A2 Substituted pyrazolopyrimidines |
| 02/18/2009 | EP2023933A2 Acetylenic heteroaryl compounds |
| 02/18/2009 | EP2023729A2 Organic compounds |
| 02/18/2009 | EP1758907B1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 02/18/2009 | EP1675852B1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 02/18/2009 | EP1664052B1 Fused heterocycles as inhibitors of glutamate racemase (muri) |
| 02/18/2009 | EP1575952B1 Synthesis of heteroaryl acetamides |
| 02/18/2009 | CN101370814A Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents |
| 02/18/2009 | CN101370813A Dimers and adducts of 6-[substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 02/18/2009 | CN101370812A Fused heterocyclic compound |
| 02/18/2009 | CN101370811A Imidazopyrazines as protein kinase inhibitors |
| 02/18/2009 | CN101367836A Preparation method for high temperature inhibitor for oil refining apparatus and uses thereof |
| 02/18/2009 | CN101367835A High temperature inhibitor for oil refining apparatus |
| 02/18/2009 | CN101367820A Pyrazole-[1,5-a]indole fluoroform sulphonate-4-dimethylamino-benzyl alkene derivant and method of preparing the same |
| 02/18/2009 | CN101367819A 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof |
| 02/18/2009 | CN101367793A Amino-quinazoline derivative with antineoplastic activity and its salts |
| 02/17/2009 | US7491831 PPAR active compounds |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491729 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | US7491716 Glycogen synthase kinase-3 inhibitors such as [1-(4-Imidazo[1,2-a]pyridin-3-yl-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-6,7-dihydro-6H-[1,4]diazepino[6,7,1-hi]indol-6-yl]-[morpholin-4-yl]methylenecyanamide, used for treating diabetes, Alzheimer's disease and for stimulating bone deposition in mammals |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/12/2009 | WO2009021169A2 (7h-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| 02/12/2009 | WO2009020990A1 2- [ (2-{phenylamino}-1h-pyrrolo [2, 3-d] pyrimidin-4-yl) amino] benzamide derivatives as igf-1r inhibitors for the treatment of cancer |
| 02/12/2009 | WO2009020616A1 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| 02/12/2009 | WO2009020580A1 Gamma secretase modulators |
| 02/12/2009 | WO2009019286A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 02/12/2009 | WO2008157208A3 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 02/12/2009 | WO2008156614A3 Imidazopyrazines as protein kinase inhibitors |
| 02/12/2009 | WO2008155421A3 Indolin-2-ones and aza-indolin-2-ones |
| 02/12/2009 | WO2008008539A3 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 02/12/2009 | US20090042912 DIPHENYLIMIDAZOLYL COMPOUNDS AS INHIBITORS OF beta-SECRETASE |
| 02/12/2009 | US20090042893 Kinase inhibitors, compositions comprising them, and methods of their use |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042859 Spiro-condensed indoline derivatives as pesticides |
| 02/12/2009 | US20090042856 Pyridazinone derivatives used for the treatment of pain |
| 02/12/2009 | US20090042852 Novel Pyridine Compounds |
| 02/12/2009 | US20090042837 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/12/2009 | US20090041721 Arylalkoxyl hepatitis c virus protease inhibitors |
| 02/12/2009 | CA2695857A1 Kinase inhibitors, compositions comprising them, and methods of their use |
| 02/12/2009 | CA2695616A1 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| 02/12/2009 | CA2695543A1 Gamma secretase modulators |
| 02/12/2009 | CA2691529A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 02/11/2009 | EP2022792A1 Novel compound having affinity to amyloid |
| 02/11/2009 | EP1819709B1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 02/11/2009 | EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders |
| 02/11/2009 | EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/11/2009 | EP1175470A4 Electronic device comprising organic compound having p-type semiconducting characteristics |
| 02/11/2009 | CN101365702A Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 02/11/2009 | CN101365701A 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
| 02/11/2009 | CN101362765A 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 02/11/2009 | CN101362764A 5,7-diaminopyrazolo '4,3-d!pyrimidines with PDE-5 inhibiting activity |
| 02/10/2009 | US7488819 Coordination sites of four nitrogen-containing groups of of imino, amido and amino groups, and has the nitrogen atoms of the four nitrogen-containing groups as coordinating atoms in one plane; metal complex assembly; acceptor and a donor interacting with each other; nanostructure; semiconductors |
| 02/10/2009 | US7488817 Metal complex protein kinase inhibitors |
| 02/10/2009 | US7488735 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation |
| 02/10/2009 | US7488729 Polymorphic forms of ziprasidone and its hydrochloride salt and process for preparation thereof |
| 02/10/2009 | US7488727 Thiazole compounds useful as inhibitors of protein kinase |
| 02/10/2009 | US7488542 OLEDs doped with phosphorescent compounds |
| 02/05/2009 | WO2009016516A2 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 02/05/2009 | WO2009016460A2 Pyrazole compounds and their use as raf inhibitors |
| 02/05/2009 | WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 02/05/2009 | WO2009016251A1 Process for the resolution of zopiclone and intermediate compounds |
| 02/05/2009 | WO2009016132A1 Pyrrolopyrimidines |
| 02/05/2009 | WO2008122534A3 Non-nucleoside reverse transcriptase inhibitors |
| 02/05/2009 | WO2008047951A3 An alzheimer' s disease progression inhibitor containing heterocyclic compound |
| 02/05/2009 | WO2007127173A4 Therapeutic compounds |
| 02/05/2009 | US20090036689 Substituted indolocarbazoles |
| 02/05/2009 | US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders |
| 02/05/2009 | US20090036681 S)-zopiclone N-acetyl-D-glutamate, (S)-zopiclone N-acetyl-D-aspartate, or (S)-zopiclone N-acetyl-D-methionate; optically pure diastereoisomeric salt; hypnotic, sedative, tranquilizing, anxiolytic, muscle-relaxant and anticonvulsant properties |
| 02/05/2009 | US20090036678 Process for the synthesis of E1 activating enzyme inhibitors |
| 02/05/2009 | US20090036472 Azabicyclo derivatives as anti-inflammatory agents |
| 02/05/2009 | US20090036471 Triazolopyrimidine Derivatives As Glycogen Synthase Kinase 3 Inhibitors |
| 02/05/2009 | US20090036453 Pyrrolopyridazinone Compound |
| 02/05/2009 | US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 02/05/2009 | US20090036441 Indole Derivatives With Antitumor Activity |
| 02/05/2009 | US20090036431 Cytotoxic Agents Comprising New Tomaymycin Derivatives |
| 02/05/2009 | US20090036427 Substituted bicyclic pyrimidone derivatives |
| 02/05/2009 | US20090036422 Monoamide derivatives as orexin receptor antagonists |
| 02/05/2009 | DE19830040B4 Neue Cyclopentadiquinoxalin-Derivate New Cyclopentadiquinoxalin derivatives |
| 02/05/2009 | CA2695254A1 Process for the resolution of zopiclone and intermediate compounds |
| 02/05/2009 | CA2695114A1 Pyrazole compounds and their use as raf inhibitors |
| 02/05/2009 | CA2693715A1 Pyrrolopyrimidines |
| 02/05/2009 | CA2693551A1 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |